<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6357">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03024164</url>
  </required_header>
  <id_info>
    <org_study_id>REACH</org_study_id>
    <nct_id>NCT03024164</nct_id>
  </id_info>
  <brief_title>Stroke Registration of Young Adults in China</brief_title>
  <acronym>REACH</acronym>
  <official_title>Stroke Registration of Young Adults in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yi Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to build the study cohort of young ischemic stroke
      population in China, and to compare the prognosis of patients with different ischemic stroke
      subtypes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 15% of all ischemic strokes (IS) occur in young adults and adolescents. Youth
      IS refers to the young ischemic stroke patients, aged 18 to 45 years old, about 5%-10% in
      all cases of cerebral apoplexy. Youth IS is different from old age IS for risk factors,
      secondary prevention standards compliance and prognosis. So it is meaningful to learn and
      study the youth IS risk factor,the secondary prevention and its relationship with prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke recurrence within 90 days</measure>
    <time_frame>90 days</time_frame>
    <description>Newly onset stroke that the time interval was less than 90 days from the original stroke event was considered as stroke recurrence. Ischemic stroke was defined as acute focal brain or retinal infarction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>1 year</time_frame>
    <description>Death direct from ischemic stroke, hemorrhagic stroke, sudden cardiac death, acute myocardial infarction, heart failure, and other cardiovascular death including cardiac arrhythmia that unrelated to sudden cardiac death, pulmonary embolism, cardiovascular intervention (unrelated to acute MI), ruptured aortic aneurysm, or peripheral arterial disease).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-stroke disability</measure>
    <time_frame>1 year</time_frame>
    <description>modified Rankin Scale(mRS)â‰¥3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other cardiovascular events</measure>
    <time_frame>1 year</time_frame>
    <description>Including nonfatal myocardial infarction and nonfatal heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular related operations and surgery</measure>
    <time_frame>1 year</time_frame>
    <description>Including carotid artery stenting(CAS), carotid endarterectomy(CEA), Coronary artery stents, PFO closure, et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic arterial embolic events</measure>
    <time_frame>1 year</time_frame>
    <description>Systemic arterial embolic events, except central nervous system, coronary artery and pulmonary artery circulation,</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Large artery atherosclerosis(LAA)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiogenic stroke(CS)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Penetrating artery disease(PAD)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Other etiology(OE)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>undetermined etiology(UE)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        acute ischemic stroke young patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 18 to 45,both genders

          -  Acute ischemic stroke ictus in 72h

          -  Willing to participate in follow-up visits

        Exclusion Criteria:

          -  Silent cerebral infarction

          -  Inability to cooperate registration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yi Yang, MD,PhD</last_name>
    <email>doctor_yangyi@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhenni Guo, MD</last_name>
    <email>zhen1ni2@163.com</email>
  </overall_contact_backup>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 18, 2017</lastchanged_date>
  <firstreceived_date>January 15, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Yi Yang</investigator_full_name>
    <investigator_title>Associate dean, Director of Cerebrovascular Disease Center</investigator_title>
  </responsible_party>
  <keyword>youth ischemic stroke; etiology; prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
